Financial reports
ARS
2023 FY
Annual report to shareholders
18 Apr 24
10-Q
2023 Q3
Quarterly report
7 Nov 23
10-Q
2023 Q2
Quarterly report
2 Aug 23
10-Q
2023 Q1
Quarterly report
4 May 23
ARS
2022 FY
Annual report to shareholders
12 Apr 23
10-K/A
2022 FY
Annual report (amended)
22 Mar 23
10-K
2022 FY
Annual report
9 Feb 23
10-Q
2022 Q3
Quarterly report
8 Nov 22
10-Q
2022 Q2
Quarterly report
28 Jul 22
Current reports
8-K
Carlyle Appoints Afsaneh M. Beschloss as an Independent Director
3 Apr 24
8-K
Carlyle Names Lindsay LoBue as Chief Operating Officer
27 Mar 24
8-K
Carlyle Reports Fourth Quarter and Full-Year 2023 Financial Results
7 Feb 24
8-K
Departure of Directors or Certain Officers
18 Jan 24
8-K
Carlyle Reports Third Quarter 2023 Financial Results
6 Nov 23
8-K
Carlyle Reports Second Quarter 2023 Financial Results
2 Aug 23
8-K
Carlyle Names John Redett as Chief Financial Officer and Head of Corporate Strategy
20 Jun 23
8-K
Departure of Directors or Certain Officers
1 Jun 23
8-K
Carlyle Reports First Quarter 2023 Financial Results
3 May 23
8-K
Carlyle Appoints Sharda Cherwoo as an Independent Director
26 Apr 23
Registration and prospectus
S-8
Registration of securities for employees
16 Jun 23
S-3ASR
Automatic shelf registration
22 Mar 23
S-8
Registration of securities for employees
13 Feb 23
S-8
Registration of securities for employees
20 Jan 23
424B3
Prospectus supplement
1 Aug 22
424B3
Prospectus supplement
22 Jun 22
424B3
Prospectus supplement
21 Mar 22
424B5
Prospectus supplement for primary offering
7 Jun 21
FWP
Free writing prospectus
4 Jun 21
424B5
Prospectus supplement for primary offering
4 Jun 21
Proxies
DEFA14A
Additional proxy soliciting materials
18 Apr 24
DEF 14A
Definitive proxy
18 Apr 24
PRE 14A
Preliminary proxy
3 Apr 24
DEFA14A
Additional proxy soliciting materials
26 Apr 23
DEFA14A
Additional proxy soliciting materials
12 Apr 23
DEF 14A
Definitive proxy
12 Apr 23
PRE 14A
Preliminary proxy
28 Mar 23
DEFA14A
Additional proxy soliciting materials
26 May 22
DEFA14A
Additional proxy soliciting materials
13 Apr 22
DEF 14A
Definitive proxy
13 Apr 22
Other
CERT
Certification of approval for exchange listing
18 May 21
UPLOAD
Letter from SEC
15 Jun 17
CORRESP
Correspondence with SEC
19 May 17
UPLOAD
Letter from SEC
3 May 17
UPLOAD
Letter from SEC
21 Oct 16
CORRESP
Correspondence with SEC
6 Oct 16
UPLOAD
Letter from SEC
23 Sep 16
UPLOAD
Letter from SEC
19 Oct 15
CORRESP
Correspondence with SEC
11 Sep 15
CORRESP
Correspondence with SEC
11 Sep 15
Ownership
4
CommScope Holding Company, Inc.
2 Apr 24
SC 13G
Q32 Bio Inc.
29 Mar 24
4
HARVEY M SCHWARTZ
5 Mar 24
SC 13D/A
Carlyle Group Management L.L.C.
5 Mar 24
4
HARVEY M SCHWARTZ
16 Feb 24
144
Notice of proposed sale of securities
15 Feb 24
SC 13G/A
VANGUARD GROUP INC
13 Feb 24
4
Jasper Therapeutics, Inc.
12 Feb 24
SC 13D/A
Jasper Therapeutics, Inc.
12 Feb 24
SC 13G/A
ZoomInfo Technologies Inc.
12 Feb 24